Clinical Trial Update: Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement [NA]

View source ↗

Summary

A completed clinical trial evaluating a CanXida anti-fungal supplement for Candida infections. The excerpt does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Albicans Infection
• Candida Infection
• Candida Systemic Infection

Drugs mentioned

• CanXida antifungal supplement (antifungal supplement)

Snippet

Sponsor: CanXida | Conditions: Candida Systemic, Candida Albicans Infection | NA | Status: COMPLETED